UroMed launching Impress Softpatch female incontinence device in early 1998, company tells analysts.
This article was originally published in The Gray Sheet
Executive SummaryUROMED LAUNCHING IMPRESS SOFTPATCH FEMALE URINARY INCONTINENCE DEVICE in the U.S. the first half of 1998 following scale up of manufacturing at the firm's Needham, Massachusetts facility. The single-use, soft foam patch device, which gained 510(k) clearance in mid-1996, is applied using a gel-adhesive strip to the labia of a patient to prevent urinary leakage.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.